カテゴリー： 世界, 医療/バイオ, Grand View Research

神経血管塞栓装置のグローバル市場2023-2030：塞栓コイル、流路転換装置

【英語タイトル】Neurovascular Embolization Devices Market Size, Share & Trends Analysis Report By Product (Embolic Coils, Flow Diversion Devices), By End-use (Hospitals, Specialty Clinics), By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NVB084）・商品コード：GRV23NVB084
・発行会社（調査会社）：Grand View Research
・発行日：2023年10月5日
・ページ数：110
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

神経血管塞栓装置市場の成長と動向
Grand View Research, Inc.の最新レポートによると、神経血管塞栓装置の世界市場規模は、2023年から2030年にかけて年平均成長率6.60％を記録し、2030年には17億6000万米ドルに達すると予測されています。脳卒中発症率の増加、低侵襲手技の需要増、業界主要企業間の合併や提携が市場成長の原動力。可処分所得が拡大し、医療へのアクセスが改善された発展途上国で市場は急成長しています。その結果、機器メーカーは新たな成長機会を得ており、世界的な市場拡大が見込まれています。

世界中で脳卒中の有病率が上昇していることが、市場の成長を促す主な要因です。脳卒中は身体障害や死亡の主な原因の一つであり、世界人口の高齢化に伴い、糖尿病や高血圧などの脳卒中の危険因子がより一般的になっています。その結果、脳卒中の治療や予防に使用される神経血管塞栓ツールのニーズが高まっています。予測期間中、脳動脈瘤と脳卒中の有病率が世界市場の拡大に拍車をかけると予想されます。

例えば、世界脳卒中機構は、2022年までに脳卒中の有病率はすでに流行レベルに達していると予測しています。今年初めて脳卒中を経験した人は世界で1,220万人以上と推定され、その結果650万人が死亡し、25歳以上の成人の4人に1人が生涯に脳卒中を患うと予測されています。

神経血管塞栓術の技術開発が進み、治療の有効性と安全性が高まっています。主要な医療機器メーカーは、神経血管業界における製品ラインを拡大し、競合を増やし、技術革新を促進しています。主要な業界プレーヤーは、業界の成長を後押しする神経血管塞栓術分野の進歩のために、製品の製造と開発に携わっています。例えば、2023年2月には、ドイツのEMBO-Post Market Surveillance Registryの最初の患者がShape Memory Medicalによって治療されました。末梢血管塞栓術は、IMPEDEとIMPEDE-FX塞栓プラグを使って行われました。

神経血管塞栓装置市場のハイライト

- 2022年の市場シェアは塞栓用コイルが77.66%で圧倒的です。塞栓用コイル市場は、認知度の向上、治療方法の改善、コイル技術の発展により、年々着実に拡大しています。

- 最終用途別では、病院が2022年に71.87%のシェアを獲得しました。神経血管塞栓装置の使用は、神経血管疾患に関して病院が患者やその家族に教育する治療選択肢の1つです。病院がその能力を向上させ、最新の医療技術を採用し続けるにつれて、これらの機器に対する需要は引き続き堅調に推移すると予想されます。

- 2022年の市場シェアは26.44%で北米が圧倒的です。同市場は競争が激しく、既存企業も新興企業も製品の革新、合併、買収、提携を通じて市場シェアの獲得に努めています。このため、この地域の主要プレーヤーの存在が業界の成長を後押ししています。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. 神経血管塞栓装置の市場変数・傾向・範囲
第4章. 神経血管塞栓装置の世界市場：製品別予測・傾向分析
第5章. 神経血管塞栓装置の世界市場：最終用途別予測・傾向分析
第6章. 神経血管塞栓装置の世界市場：地域別予測・傾向分析
第7章. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End-use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Neurovascular Embolization Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing incidence of neurovascular disorders
3.4.1.2. Technological advancements
3.4.1.3. Improved disease diagnostic techniques
3.4.2. Market restraint analysis
3.4.2.1. High cost of devices
3.5. Neurovascular Embolization Devices Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Neurovascular Embolization Devices Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Embolic Coils
4.1.2. Flow Diversion Devices
4.1.3. Liquid Embolic Agents
4.1.4. Aneurysm Clips
4.2. Product Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Neurovascular Embolization Devices Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Embolic Coils
4.5.1.1. Embolic coils market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Flow Diversion Devices
4.5.2.1. Flow diversion devices market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Liquid Embolic Agents
4.5.3.1. Liquid embolic agents market estimates and forecast 2018 to 2030 (USD Million)
4.5.4. Aneurysm Clips
4.5.4.1. Aneurysm clips market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Neurovascular Embolization Devices Market: End-use Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Hospitals
5.1.2. Specialty Clinics
5.1.3. Others
5.2. End-use Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Neurovascular Embolization Devices Market by End-use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Hospitals
5.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Specialty Clinics
5.5.2.1. Specialty clinics market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Others
5.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Neurovascular Embolization Devices Market: Regional Estimates & Trend Analysis
6.1. Regional market share analysis, 2022 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Regional Market Share and Leading Players, 2022
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030
6.6. North America
6.6.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.6.2. U.S.
6.6.2.1. Key country dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory framework
6.6.2.4. Reimbursement scenario
6.6.2.5. U.S. market estimates and forecasts, 2018 – 2030
6.6.3. Canada
6.6.3.1. Key country dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory framework
6.6.3.4. Reimbursement scenario
6.6.3.5. Canada market estimates and forecasts, 2018 – 2030
6.7. Europe
6.7.1. UK
6.7.1.1. Key country dynamics
6.7.1.2. Competitive Scenario
6.7.1.3. Regulatory framework
6.7.1.4. Reimbursement scenario
6.7.1.5. UK market estimates and forecasts, 2018 – 2030
6.7.2. Germany
6.7.2.1. Key country dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory framework
6.7.2.4. Reimbursement scenario
6.7.2.5. Germany market estimates and forecasts, 2018 – 2030
6.7.3. France
6.7.3.1. Key country dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory framework
6.7.3.4. Reimbursement scenario
6.7.3.5. France market estimates and forecasts, 2018 – 2030
6.7.4. Italy
6.7.4.1. Key country dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory framework
6.7.4.4. Reimbursement scenario
6.7.4.5. Italy market estimates and forecasts, 2018 – 2030
6.7.5. Spain
6.7.5.1. Key country dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory framework
6.7.5.4. Reimbursement scenario
6.7.5.5. Spain market estimates and forecasts, 2018 – 2030
6.7.6. Denmark
6.7.6.1. Key country dynamics
6.7.6.2. Competitive Scenario
6.7.6.3. Regulatory framework
6.7.6.4. Reimbursement scenario
6.7.6.5. Denmark market estimates and forecasts, 2018 – 2030
6.7.7. Sweden
6.7.7.1. Key country dynamics
6.7.7.2. Competitive Scenario
6.7.7.3. Regulatory framework
6.7.7.4. Reimbursement scenario
6.7.7.5. Sweden market estimates and forecasts, 2018 – 2030
6.7.8. Norway
6.7.8.1. Key country dynamics
6.7.8.2. Competitive Scenario
6.7.8.3. Regulatory framework
6.7.8.4. Reimbursement scenario
6.7.8.5. Norway market estimates and forecasts, 2018 – 2030
6.8. Asia Pacific
6.8.1. Japan
6.8.1.1. Key country dynamics
6.8.1.2. Competitive Scenario
6.8.1.3. Regulatory framework
6.8.1.4. Reimbursement scenario
6.8.1.5. Japan market estimates and forecasts, 2018 – 2030
6.8.2. India
6.8.2.1. Key country dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory framework
6.8.2.4. Reimbursement scenario
6.8.2.5. India market estimates and forecasts, 2018 – 2030
6.8.3. China
6.8.3.1. Key country dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory framework
6.8.3.4. Reimbursement scenario
6.8.3.5. China market estimates and forecasts, 2018 – 2030
6.8.4. South Korea
6.8.4.1. Key country dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory framework
6.8.4.4. Reimbursement scenario
6.8.4.5. South Korea market estimates and forecasts, 2018 – 2030
6.8.5. Australia
6.8.5.1. Key country dynamics
6.8.5.2. Competitive Scenario
6.8.5.3. Regulatory framework
6.8.5.4. Reimbursement scenario
6.8.5.5. Australia market estimates and forecasts, 2018 – 2030
6.8.6. Thailand
6.8.6.1. Key country dynamics
6.8.6.2. Competitive Scenario
6.8.6.3. Regulatory framework
6.8.6.4. Reimbursement scenario
6.8.6.5. Thailand market estimates and forecasts, 2018 – 2030
6.9. Latin America
6.9.1. Brazil
6.9.1.1. Key country dynamics
6.9.1.2. Competitive Scenario
6.9.1.3. Regulatory framework
6.9.1.4. Reimbursement scenario
6.9.1.5. Brazil market estimates and forecasts, 2018 – 2030
6.9.2. Mexico
6.9.2.1. Key country dynamics
6.9.2.2. Competitive Scenario
6.9.2.3. Regulatory framework
6.9.2.4. Reimbursement scenario
6.9.2.5. Mexico market estimates and forecasts, 2018 – 2030
6.9.3. Argentina
6.9.3.1. Key country dynamics
6.9.3.2. Competitive Scenario
6.9.3.3. Regulatory framework
6.9.3.4. Reimbursement scenario
6.9.3.5. Argentina market estimates and forecasts, 2018 – 2030
6.10. MEA
6.10.1. South Africa
6.10.1.1. Key country dynamics
6.10.1.2. Competitive Scenario
6.10.1.3. Regulatory framework
6.10.1.4. Reimbursement scenario
6.10.1.5. South Africa market estimates and forecasts, 2018 – 2030
6.10.2. Saudi Arabia
6.10.2.1. Key country dynamics
6.10.2.2. Competitive Scenario
6.10.2.3. Regulatory framework
6.10.2.4. Reimbursement scenario
6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 – 2030
6.10.3. UAE
6.10.3.1. Key country dynamics
6.10.3.2. Competitive Scenario
6.10.3.3. Regulatory framework
6.10.3.4. Reimbursement scenario
6.10.3.5. UAE market estimates and forecasts, 2018 – 2030
6.10.4. Kuwait
6.10.4.1. Key country dynamics
6.10.4.2. Competitive Scenario
6.10.4.3. Regulatory framework
6.10.4.4. Reimbursement scenario
6.10.4.5. Kuwait market estimates and forecasts, 2018 – 2030
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2022
7.3.4. Medtronic
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Stryker
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. MicroVention Inc.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Cerenovus
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Integra LifeSciences
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Penumbra, Inc.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Balt SAS
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. B. Braun Melsungen AG
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Phenox GmbH
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives

List of Tables

Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global neurovascular embolization devices market, by region 2018 - 2030 (USD Million)
Table 4. Global neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 5. Global neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 6. North America neurovascular embolization devices market, by country, 2018 - 2030 (USD Million)
Table 7. North America neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 8. North America neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 9. U.S. neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 10. U.S. neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 11. Canada neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 12. Canada neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 13. Europe neurovascular embolization devices market, by country, 2018 - 2030 (USD Million)
Table 14. Europe neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 15. Europe neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 16. UK neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 17. UK neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 18. Germany neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 19. Germany neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 20. France neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 21. France neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 22. Italy neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 23. Italy neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 24. Spain neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 25. Spain neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 26. Denmark neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 27. Denmark neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 28. Sweden neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 29. Sweden neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 30. Norway neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 31. Norway neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 32. Asia Pacific neurovascular embolization devices market, by country, 2018 - 2030 (USD Million)
Table 33. Asia Pacific neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 34. Asia Pacific neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 35. Japan neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 36. Japan neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 37. China neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 38. China neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 39. India neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 40. India neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 41. Australia neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 42. Australia neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 43. Thailand neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 44. Thailand neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 45. South Korea neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 46. South Korea neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 47. Latin America neurovascular embolization devices market, by country, 2018 - 2030 (USD Million)
Table 48. Latin America neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 49. Latin America neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 50. Brazil neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 51. Brazil neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 52. Mexico neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 53. Mexico neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 54. Argentina neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 55. Argentina neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 56. MEA neurovascular embolization devices market, by country, 2018 - 2030 (USD Million)
Table 57. MEA neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 58. MEA neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 59. South Africa neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 60. South Africa neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 61. Saudi Arabia neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 62. Saudi Arabia neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 63. UAE neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 64. UAE neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million)
Table 65. Kuwait neurovascular embolization devices market, by product, 2018 - 2030 (USD Million)
Table 66. Kuwait neurovascular embolization devices market, by end-use, 2018 - 2030 (USD Million) 

★調査レポート[神経血管塞栓装置のグローバル市場2023-2030：塞栓コイル、流路転換装置] (コード：GRV23NVB084)販売に関する免責事項を必ずご確認ください。
★調査レポート[神経血管塞栓装置のグローバル市場2023-2030：塞栓コイル、流路転換装置]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の神経血管デバイス市場（～2028年）：病態別（脳動脈瘤（塞栓コイル）、虚血性脳卒中（血栓回収器、吸引器、マイクロカテーテル）、AVM（液状塞栓剤））、エンドユーザー別（病院）、地域別
  • 世界の神経インターベンション装置市場2023年-2032年：製品別（ステント、塞栓コイル、カテーテル、ワイヤー、その他）、疾患別（脳動脈瘤、脳卒中、その他）、用途別（病院、外来手術センター、その他）
  • 世界の塞栓療法製品市場予測2023-2029：塞栓ミクロスフェア、塞栓粒子、塞栓コイル、液体塞栓剤、塞栓補助材料、その他
  • 世界の塞栓製品市場予測2023-2029：塞栓ミクロスフェア、塞栓粒子、塞栓コイル、液体塞栓剤、塞栓補助材料、その他
  • 塞栓療法製品のグローバル市場2023年：塞栓ミクロスフェア、塞栓粒子、塞栓コイル、液体塞栓剤、塞栓補助材料、その他
  • バルーン膨張装置の世界市場2023-2030：市場規模、シェア、動向分析
  • バルーン拡張装置の世界市場2023-2030：市場規模、シェア、動向分析
  • 世界のマイクロダーマブレーション機器市場2023-2030：用途別（アンチエイジング、ニキビ・傷跡）、種類別（クリスタル、ダイヤモンド）、エンドユーザー別（家庭用、診療所・ビューティーセンター）、地域別
  • 関節内補充療法の世界市場2023-2030：市場規模、シェア、動向分析

    • ◆H&Iグローバルリサーチのお客様（例）◆